- Home
- VZLA vs KALV Comparison
VZLA vs KALV Comparison
Compare VZLA & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VZLA
- KALV
- Stock Information
- Founded
- VZLA 2017
- KALV N/A
- Country
- VZLA Canada
- KALV United States
- Employees
- VZLA 139
- KALV N/A
- Industry
- VZLA
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- VZLA
- KALV Health Care
- Exchange
- VZLA Nasdaq
- KALV Nasdaq
- Market Cap
- VZLA 634.6M
- KALV 563.1M
- IPO Year
- VZLA N/A
- KALV N/A
- Fundamental
- Price
- VZLA $2.18
- KALV $12.99
- Analyst Decision
- VZLA Strong Buy
- KALV Strong Buy
- Analyst Count
- VZLA 4
- KALV 8
- Target Price
- VZLA $4.06
- KALV $24.83
- AVG Volume (30 Days)
- VZLA 2.7M
- KALV 658.2K
- Earning Date
- VZLA 12-13-2024
- KALV 03-12-2025
- Dividend Yield
- VZLA N/A
- KALV N/A
- EPS Growth
- VZLA N/A
- KALV N/A
- EPS
- VZLA N/A
- KALV N/A
- Revenue
- VZLA N/A
- KALV N/A
- Revenue This Year
- VZLA N/A
- KALV N/A
- Revenue Next Year
- VZLA N/A
- KALV N/A
- P/E Ratio
- VZLA N/A
- KALV N/A
- Revenue Growth
- VZLA N/A
- KALV N/A
- 52 Week Low
- VZLA $1.27
- KALV $7.30
- 52 Week High
- VZLA $2.47
- KALV $15.50
- Technical
- Relative Strength Index (RSI)
- VZLA 51.39
- KALV 63.87
- Support Level
- VZLA $2.07
- KALV $12.10
- Resistance Level
- VZLA $2.30
- KALV $12.82
- Average True Range (ATR)
- VZLA 0.15
- KALV 0.90
- MACD
- VZLA 0.01
- KALV 0.16
- Stochastic Oscillator
- VZLA 77.60
- KALV 94.94
About VZLA Vizsla Silver Corp.
Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.